ZHENDE MEDICAL CO LTD

ZHENDE MEDICAL CO LTD — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014
+Revenue	4.3B	4.1B	6.1B	5.1B	10.4B	1.9B	1.4B	1.3B	1.0B	1.0B	987.0M
Revenue Growth %	3.3%	-32.8%	20.5%	-51.0%	456.7%	30.7%	9.4%	26.2%	1.4%	3.4%	--
Total Revenue	4.3B	4.1B	6.1B	5.1B	10.4B	1.9B	1.4B	1.3B	1.0B	1.0B	987.0M
Cost Of Revenue	2.8B	2.7B	4.0B	3.3B	5.5B	1.3B	981.0M	920.0M	707.0M	716.0M	768.0M
+Gross Profit	1.5B	1.4B	2.1B	1.8B	4.9B	599.0M	448.0M	386.0M	328.0M	305.0M	219.0M
Gross Margin %	34.0%	34.7%	35.0%	34.8%	47.0%	32.1%	31.4%	29.6%	31.7%	29.9%	22.2%
Total Operating Cost	3.9B	4.0B	5.3B	4.4B	6.9B	1.7B	1.3B	1.2B	962.0M	957.0M	968.0M
Selling Expenses	369.0M	381.0M	477.0M	367.0M	492.0M	188.0M	118.0M	89.3M	77.4M	68.8M	45.0M
Admin Expenses	522.0M	513.0M	507.0M	442.0M	386.0M	169.0M	111.0M	101.0M	137.0M	130.0M	102.0M
Rd Expenses	135.0M	139.0M	227.0M	153.0M	260.0M	51.0M	56.9M	43.7M	--	--	--
Finance Expenses	-17.6M	-20.8M	2.1M	27.2M	105.0M	25.1M	23.8M	29.6M	17.0M	28.8M	44.2M
+Operating Income	492.0M	226.0M	813.0M	822.0M	3.5B	200.0M	153.0M	148.0M	79.2M	82.5M	16.3M
Operating Margin %	11.5%	5.5%	13.2%	16.1%	34.0%	10.7%	10.7%	11.3%	7.6%	8.1%	1.7%
Non Operating Income	571,800	662,900	1.7M	2.6M	1.2M	94,600	694,800	580,900	24.0M	10.4M	12.1M
Non Operating Expenses	16.9M	7.7M	12.7M	4.6M	5.1M	1.2M	2.6M	1.2M	3.6M	1.6M	4.1M
Investment Income	11.1M	6.8M	-59.8M	36.7M	14.4M	-4.0M	-7.5M	-232,300	6.8M	25.1M	-2.7M
Fair Value Change Income	-12.2M	-21.1M	-11.2M	-2.7M	-2.8M	6.8M	--	--	--	--	--
Asset Disposal Income	93.4M	-16.0M	-13.5M	-613,800	42,700	-463,600	16.3M	346,700	-86,600	-6.2M	--
Asset Impairment Loss	41.8M	207.0M	75.6M	36.1M	101.0M	7.3M	12.4M	-1.3M	10.0M	5.9M	2.9M
Other Income	49.5M	78.7M	90.5M	90.6M	32.2M	57.9M	34.6M	38.9M	--	--	--
Income Before Tax	475.0M	219.0M	802.0M	820.0M	3.5B	199.0M	152.0M	147.0M	99.6M	91.3M	24.3M
Income Tax	78.2M	5.5M	100.0M	99.0M	561.0M	22.7M	21.7M	25.2M	16.8M	12.0M	2.3M
+Net Income	397.0M	213.0M	702.0M	721.0M	3.0B	177.0M	130.0M	122.0M	82.9M	79.2M	22.0M
Net Margin %	9.3%	5.2%	11.4%	14.2%	28.6%	9.5%	9.1%	9.3%	8.0%	7.8%	2.2%
Net Income Attributable	385.0M	198.0M	680.0M	596.0M	2.5B	157.0M	130.0M	122.0M	82.8M	79.1M	21.8M
Minority Interest	12.0M	15.0M	21.9M	125.0M	422.0M	19.7M	-324,700	345,400	41,000	189,900	212,000
Eps Basic	1.45	0.74	2.87	2.64	12.50	0.80	1.01	1.62	1.11	--	--
Eps Diluted	1.45	0.74	2.87	2.63	12.50	0.80	1.01	1.62	1.11	--	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014
Cash And Equivalents	596.0M	1.1B	2.1B	1.4B	1.8B	646.0M	302.0M	114.0M	63.5M	217.0M	93.6M
Trading Financial Assets	232.0M	156.0M	99.7M	5.2M	204.0M	40.4M	--	--	--	--	--
Accounts Receivable	757.0M	540.0M	768.0M	690.0M	664.0M	373.0M	267.0M	189.0M	178.0M	173.0M	174.0M
Notes Receivable	--	248,500	--	--	985,100	950,600	4.2M	--	--	250,000	1.6M
Notes And Accounts Receivable	757.0M	540.0M	768.0M	690.0M	665.0M	374.0M	271.0M	189.0M	178.0M	173.0M	176.0M
Prepayments	71.2M	51.1M	161.0M	191.0M	141.0M	48.4M	24.5M	32.7M	20.1M	6.6M	10.1M
Inventory	771.0M	801.0M	930.0M	833.0M	1.1B	431.0M	376.0M	208.0M	211.0M	147.0M	168.0M
Total Current Assets	2.6B	2.7B	4.1B	3.2B	4.4B	1.6B	1.0B	576.0M	495.0M	746.0M	577.0M
Long Term Equity Investment	122.0M	123.0M	72.7M	19.7M	--	573,800	637,300	817,700	--	--	--
Fixed Assets	--	2.4B	2.0B	1.6B	959.0M	521.0M	490.0M	538.0M	497.0M	387.0M	411.0M
Fixed Assets Total	2.6B	2.4B	2.0B	1.6B	959.0M	521.0M	490.0M	538.0M	497.0M	387.0M	411.0M
Construction In Progress	--	388.0M	514.0M	514.0M	578.0M	236.0M	140.0M	55.8M	11.7M	24.6M	11.0M
Construction In Progress Total	562.0M	388.0M	514.0M	514.0M	578.0M	236.0M	140.0M	55.8M	11.7M	24.6M	11.0M
Intangible Assets	710.0M	607.0M	564.0M	445.0M	226.0M	185.0M	132.0M	94.8M	97.3M	94.4M	73.5M
Long Term Deferred Expenses	2.5M	2.3M	3.3M	3.9M	792,200	1.2M	1.5M	--	--	--	--
Total Non Current Assets	4.9B	4.5B	3.8B	3.2B	2.0B	1.1B	818.0M	718.0M	633.0M	529.0M	533.0M
Total Assets	7.6B	7.3B	7.9B	6.4B	6.4B	2.7B	1.9B	1.3B	1.1B	1.3B	1.1B
Short Term Borrowings	267.0M	220.0M	124.0M	661.0M	358.0M	292.0M	360.0M	410.0M	390.0M	434.0M	617.0M
Accounts Payable	463.0M	398.0M	692.0M	604.0M	615.0M	187.0M	189.0M	134.0M	116.0M	93.7M	132.0M
Advance Receipts	--	--	--	--	--	18.3M	3.8M	3.4M	7.8M	9.0M	10.3M
Contract Liabilities	26.2M	44.9M	144.0M	47.8M	88.2M	--	--	--	--	--	--
Total Current Liabilities	1.2B	1.2B	1.5B	1.6B	1.7B	798.0M	680.0M	663.0M	609.0M	997.0M	948.0M
Long Term Borrowings	283.0M	200.0M	388.0M	145.0M	95.1M	100.0M	--	--	--	--	48.0M
Total Non Current Liabilities	520.0M	490.0M	621.0M	379.0M	194.0M	471.0M	45.6M	70.6M	80.9M	15.8M	56.1M
Total Liabilities	1.7B	1.7B	2.1B	2.0B	1.9B	1.3B	725.0M	734.0M	690.0M	1.0B	1.0B
Paid In Capital	266.0M	266.0M	266.0M	227.0M	227.0M	140.0M	100.0M	75.0M	75.0M	67.0M	18.9M
Capital Reserve	1.8B	1.8B	1.8B	896.0M	1.0B	659.0M	699.0M	290.0M	290.0M	122.0M	89.1M
Surplus Reserve	225.0M	208.0M	197.0M	132.0M	114.0M	26.4M	18.5M	12.4M	4.9M	11.2M	5.3M
Retained Earnings	3.4B	3.1B	3.4B	2.9B	2.8B	420.0M	306.0M	182.0M	67.5M	58.9M	-14.2M
Minority Equity	253.0M	239.0M	215.0M	373.0M	284.0M	40.9M	935,800	960,500	725,300	3.8M	6.6M
Equity Attributable	5.6B	5.4B	5.5B	4.1B	4.2B	1.4B	1.1B	559.0M	437.0M	259.0M	99.1M
Total Equity	5.9B	5.6B	5.8B	4.4B	4.5B	1.4B	1.1B	560.0M	438.0M	262.0M	106.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014
Cash From Sales	4.3B	4.5B	6.5B	5.5B	10.7B	1.8B	1.4B	1.3B	1.0B	1.1B	984.0M
Tax Refunds Received	169.0M	167.0M	228.0M	207.0M	190.0M	115.0M	146.0M	96.9M	73.9M	80.4M	87.8M
Total Operating Cash Inflow	4.5B	4.9B	6.9B	5.9B	11.1B	2.1B	1.7B	1.5B	1.3B	1.5B	1.8B
Cash Paid For Goods	2.6B	2.7B	4.0B	3.1B	6.2B	1.2B	1.1B	832.0M	685.0M	667.0M	764.0M
Cash Paid To Employees	922.0M	1.0B	1.0B	834.0M	600.0M	379.0M	272.0M	234.0M	189.0M	181.0M	155.0M
Taxes Paid	246.0M	332.0M	266.0M	683.0M	542.0M	68.4M	94.4M	75.6M	75.5M	60.9M	45.1M
Total Operating Cash Outflow	4.1B	4.4B	5.7B	5.1B	8.0B	1.9B	1.6B	1.3B	1.2B	1.4B	1.7B
Operating Cash Flow	461.0M	452.0M	1.2B	818.0M	3.1B	198.0M	20.2M	191.0M	139.0M	143.0M	83.6M
Total Investing Cash Inflow	1.4B	431.0M	149.0M	1.3B	940.0M	222.0M	806.0M	3.1M	373.0M	270.0M	462.0M
Total Investing Cash Outflow	2.2B	1.5B	1.1B	1.8B	2.7B	541.0M	967.0M	148.0M	323.0M	403.0M	522.0M
Investing Cash Flow	-768.0M	-1.1B	-993.0M	-554.0M	-1.8B	-319.0M	-162.0M	-145.0M	50.2M	-133.0M	-59.8M
Cash From Borrowings	1.4B	917.0M	1.8B	885.0M	945.0M	1.3B	666.0M	527.0M	581.0M	1.1B	1.1B
Dividends And Interest Paid	159.0M	424.0M	333.0M	555.0M	284.0M	58.3M	21.2M	21.4M	22.8M	37.8M	60.1M
Debt Repayments	1.4B	917.0M	2.0B	533.0M	892.0M	866.0M	716.0M	507.0M	625.0M	1.3B	1.1B
Total Financing Cash Inflow	1.4B	937.0M	2.9B	938.0M	945.0M	1.4B	1.1B	527.0M	723.0M	2.0B	1.1B
Total Financing Cash Outflow	1.6B	1.4B	2.4B	1.3B	1.2B	928.0M	770.0M	544.0M	989.0M	1.9B	1.1B
Financing Cash Flow	-169.0M	-423.0M	456.0M	-380.0M	-278.0M	428.0M	349.0M	-16.7M	-266.0M	46.3M	-27.3M
Net Change In Cash	-455.0M	-1.0B	706.0M	-155.0M	956.0M	311.0M	195.0M	22.3M	-67.2M	69.1M	-6.3M
Ending Cash Balance	589.0M	1.0B	2.1B	1.4B	1.5B	553.0M	242.0M	47.7M	25.3M	92.5M	23.4M
Capex	770.0M	599.0M	754.0M	695.0M	1.1B	274.0M	227.0M	144.0M	159.0M	23.1M	57.9M